We highlight key aspects in the design and interpretation of the results of the dose escalation phase II maribavir study that may have contributed to the negative findings on the phase III trials.
Presented in the Results section are findings from the Phase 1 focus groups on acceptability of oral health education generally, acceptability of curriculum content, preferred activities and lesson format.
While the bulk of our discussion concerns the mechanistic traits that enable individuals in range expanding populations to establish and persist in new habitat, next we briefly address recent findings on the dispersal phase of range change.
On the basis of this finding, the phase stability and the interchange energies between Al and Ti in the next nearest neighbors of X Al Ti (X: Ti, V, Cr, Mn, Fe, Co, Ni and Cu) system are discussed.
A pilot SCP was developed based on the Phase 1 findings, consisting of multiple components.
Based on the Phase I findings, we decided to examine group differences more closely in Phase II to ensure that users' needs for these practice tools were met.
Following the development of the pilot SCP based on the Phase 1 findings, an additional 26 participants were recruited to provide feedback.
On the basis of these findings, the phase III trial, START (Stimulating Targeted Antigenic Responses To NSCLC), was initiated.
A second validation phase, based on findings of the first phase, was then performed where a diagnostic strategy was applied on consecutive patient samples.
Thus, similar to our findings on phase shifts prior to training, subjecting mice to phase shifts immediately after the training event leads to markedly reduced contextual fear conditioned freezing when tested.
Neuropathological reports on patients from the phase I and IIa studies all reported similar findings [ 88- 93].
